Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics of Repaglinide”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Early research (Phase 1)Study completedNCT04718740
What this trial is testing

A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd. 33
Early research (Phase 1)Study completedNCT01489644
What this trial is testing

Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy Volunteers

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 62
Early research (Phase 1)Study completedNCT06948747
What this trial is testing

Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants

Who this might be right for
Healthy Participants
AstraZeneca 49
Early research (Phase 1)Study completedNCT06367153
What this trial is testing

A Study in Healthy Men and Women to Test Whether BI 1569912 Influences the Amount of Repaglinide, Midazolam and Bupropion in the Blood

Who this might be right for
Healthy
Boehringer Ingelheim 18
Early research (Phase 1)Study completedNCT06503679
What this trial is testing

A Drug-drug Interaction Study Evaluating the Perpetrator Potential of LY4100511 (DC-853) on Midazolam, Repaglinide, Digoxin, Rosuvastatin in Healthy Participants

Who this might be right for
Healthy
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 49
Early research (Phase 1)Not Yet RecruitingNCT07340190
What this trial is testing

A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignancies
Novartis Pharmaceuticals 24
Early research (Phase 1)Study completedNCT00959101
What this trial is testing

Comparison of Repaglinide and Metformin Combination Tablet Versus Repaglinide and Metformin as Separate Tablets in Healthy Volunteers

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 42
Early research (Phase 1)Looking for participantsNCT07372625
What this trial is testing

Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

Who this might be right for
TP53 Y220C MutationAdvanced Solid Tumors
PMV Pharmaceuticals, Inc 14
Early research (Phase 1)Study completedNCT06494761
What this trial is testing

A Study in Healthy Men to Test Whether Zongertinib Affects How 3 Other Medicines (Midazolam, Omeprazole, and Repaglinide) Are Taken up and Processed by the Body

Who this might be right for
Healthy
Boehringer Ingelheim 16
Early research (Phase 1)Study completedNCT07235748
What this trial is testing

Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

Who this might be right for
Healthy Adult Participants
Institut de Recherches Internationales Servier (I.R.I.S.) 28
Early research (Phase 1)Study completedNCT06092931
What this trial is testing

A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants

Who this might be right for
Healthy Participants
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 28
Early research (Phase 1)Study completedNCT06165146
What this trial is testing

The Effects of Pirtobrutinib (LOXO-305) on Repaglinide (CYP2C8 Substrate) in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 16
Early research (Phase 1)Study completedNCT01780051
What this trial is testing

A Pharmacokinetic Study to Compare Co-administration of Repaglinide and Metformin HCl to Administration of Combination Preparation of Those Two Components

Who this might be right for
Diabetes Mellitus, Type 2
Dalim BioTech Co., Ltd. 48
Early research (Phase 1)Study completedNCT05236530
What this trial is testing

Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir

Who this might be right for
Malaria
Novartis Pharmaceuticals 48
Early research (Phase 1)Study completedNCT01536366
What this trial is testing

Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 27
Early research (Phase 1)Study completedNCT02305901
What this trial is testing

The Effect of Multiple Doses of BI 187004 on the Single-dose Pharmacokinetics of Repaglinide and Bupropion in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 18
Early research (Phase 1)Not Yet RecruitingNCT06601517
What this trial is testing

A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.

Who this might be right for
Healthy Adult SubjectOverweight Subject
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 30
Early research (Phase 1)UnknownNCT04664725
What this trial is testing

Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion

Who this might be right for
Prostate Cancer Patients
Jiangsu HengRui Medicine Co., Ltd. 18
Early research (Phase 1)Study completedNCT07065058
What this trial is testing

A Drug Drug Interaction Study to Evaluate the Effect of VCT220 on the Pharmacokinetics of Repaglinide, Rosuvastatin, and Digoxin in Healthy, Overweight, and Obese Subjects

Who this might be right for
Obesity &Amp; Overweight
Vincentage Pharma Co., Ltd 24
Early research (Phase 1)Study completedNCT04530981
What this trial is testing

A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST

Who this might be right for
GIST - Gastrointestinal Stromal Tumor
Deciphera Pharmaceuticals, LLC 13
Load More Results